IRISS registry study offers real-world outcomes ByLynda Charters; Reviewed by Dr Ramin KhoramniaApril 19th 2021Investigators found that a fluocinolone acetonide implant maintained good real-world vision levels in patients with diabetic macular oedema who had good baseline vision.